S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
Log in
NYSE:VAPO

Vapotherm Stock Forecast, Price & News

$29.95
-0.34 (-1.12 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$29.00
Now: $29.95
$30.88
50-Day Range
$25.10
MA: $28.46
$31.85
52-Week Range
$6.86
Now: $29.95
$54.42
Volume462,170 shs
Average Volume573,110 shs
Market Capitalization$765.82 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.47
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; tracheostomy adaptors; and ProSoft cannula to provide gentle contact with the skin. In addition, Vapotherm, Inc. offers aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.94 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone603-658-0411
Employees279

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$48.10 million
Book Value$2.55 per share

Profitability

Net Income$-51,060,000.00

Miscellaneous

Market Cap$765.82 million
Next Earnings Date11/4/2020 (Confirmed)
OptionableNot Optionable
$29.95
-0.34 (-1.12 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VAPO News and Ratings via Email

Sign-up to receive the latest news and ratings for VAPO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vapotherm (NYSE:VAPO) Frequently Asked Questions

How has Vapotherm's stock been impacted by COVID-19?

Vapotherm's stock was trading at $7.79 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VAPO stock has increased by 284.5% and is now trading at $29.95.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Vapotherm?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Vapotherm
.

When is Vapotherm's next earnings date?

Vapotherm is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Vapotherm
.

How can I listen to Vapotherm's earnings call?

Vapotherm will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Vapotherm's earnings last quarter?

Vapotherm, Inc. (NYSE:VAPO) released its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.35) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.37) by $0.02. The business had revenue of $35.15 million for the quarter, compared to the consensus estimate of $33.45 million. Vapotherm had a negative net margin of 60.31% and a negative return on equity of 62.96%. The business's revenue for the quarter was up 193.3% on a year-over-year basis.
View Vapotherm's earnings history
.

What guidance has Vapotherm issued on next quarter's earnings?

Vapotherm issued an update on its third quarter 2020 After-Hours earnings guidance on Tuesday, August, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $24-28 million, compared to the consensus revenue estimate of $18.65 million.

What price target have analysts set for VAPO?

3 equities research analysts have issued 1 year price targets for Vapotherm's shares. Their forecasts range from $53.00 to $54.00. On average, they anticipate Vapotherm's share price to reach $53.50 in the next year. This suggests a possible upside of 78.6% from the stock's current price.
View analysts' price targets for Vapotherm
.

Are investors shorting Vapotherm?

Vapotherm saw a increase in short interest in September. As of September 30th, there was short interest totaling 2,340,000 shares, an increase of 25.8% from the September 15th total of 1,860,000 shares. Based on an average trading volume of 669,800 shares, the short-interest ratio is presently 3.5 days. Currently, 16.4% of the company's stock are sold short.
View Vapotherm's Short Interest
.

Who are some of Vapotherm's key competitors?

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Square (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and Aphria (APHA).

Who are Vapotherm's key executives?

Vapotherm's management team includes the following people:
  • Mr. Joseph F. Army CPA, CPA, CEO, Pres & Director (Age 56, Pay $600.5k)
  • Mr. John Coolidge, VP of Operations (Age 59, Pay $404.23k)
  • Mr. Gregoire Ramade, Sr. VP & Chief Commercial Officer (Age 50, Pay $414.1k)
  • Mr. William Niland, Founder
  • Mr. John Landry, CFO, Sr. VP, Sec. & Treasurer (Age 47)
  • Mr. Anthony Ten Haagen, VP of Legal & Compliance
  • Ms. Lindsay Becker, VP of HR (Age 35)

When did Vapotherm IPO?

(VAPO) raised $60 million in an initial public offering on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Vapotherm's stock symbol?

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

Who are Vapotherm's major shareholders?

Vapotherm's stock is owned by many different retail and institutional investors. Top institutional investors include Taylor Frigon Capital Management LLC (0.67%), Ingalls & Snyder LLC (0.46%), Cambridge Investment Research Advisors Inc. (0.10%), BNP Paribas Arbitrage SA (0.02%), Clear Harbor Asset Management LLC (0.01%) and D Orazio & Associates Inc. (0.01%). Company insiders that own Vapotherm stock include 3X5 Partners, Llc, Anthony L Arnerich, Craig B Reynolds, Elizabeth H Weatherman, Gregoire Ramade, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army, Marina Hahn, Michael Mcqueen, Prescott General Partners Llc and Thomas W Smith.
View institutional ownership trends for Vapotherm
.

Which major investors are selling Vapotherm stock?

VAPO stock was sold by a variety of institutional investors in the last quarter, including Taylor Frigon Capital Management LLC, and Cambridge Investment Research Advisors Inc.. Company insiders that have sold Vapotherm company stock in the last year include 3X5 Partners, Llc, Craig B Reynolds, Gregoire Ramade, and Marina Hahn.
View insider buying and selling activity for Vapotherm
.

Which major investors are buying Vapotherm stock?

VAPO stock was bought by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, BNP Paribas Arbitrage SA, Clear Harbor Asset Management LLC, D Orazio & Associates Inc., and HighMark Wealth Management LLC. Company insiders that have bought Vapotherm stock in the last two years include Anthony L Arnerich, Elizabeth H Weatherman, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army, Michael Mcqueen, Prescott General Partners Llc, and Thomas W Smith.
View insider buying and selling activity for Vapotherm
.

How do I buy shares of Vapotherm?

Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vapotherm's stock price today?

One share of VAPO stock can currently be purchased for approximately $29.95.

How big of a company is Vapotherm?

Vapotherm has a market capitalization of $765.82 million and generates $48.10 million in revenue each year. The company earns $-51,060,000.00 in net income (profit) each year or ($2.74) on an earnings per share basis. Vapotherm employs 279 workers across the globe.

What is Vapotherm's official website?

The official website for Vapotherm is www.vapotherm.com.

How can I contact Vapotherm?

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at 603-658-0411 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.